Closing Thoughts on Enfortumab Vedotin Plus Pembrolizumab in Patients With Advanced Urothelial Carcinoma

Opinion
Video

Rohit Gosain, MD, and Rahul Gosain, MD, provide a summary of the key data discussed during their conversation with Jonathan E. Rosenberg, MD, on the phase 2 EV-103 trial in metastatic or locally advanced urothelial carcinoma.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content